Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 242 | 11 | 4.5 | 81 | 33.5 | 81 | 33.5 | 48 | 19.8 | 21 | 8.7 |
2015-2019 | 244 | 14 | 5.7 | 85 | 34.8 | 83 | 34.0 | 41 | 16.8 | 21 | 8.6 |
2014-2018 | 243 | 16 | 6.6 | 79 | 32.5 | 75 | 30.9 | 49 | 20.2 | 24 | 9.9 |
2013-2017 | 249 | 18 | 7.2 | 87 | 34.9 | 78 | 31.3 | 41 | 16.5 | 25 | 10.0 |
2012-2016 | 268 | 21 | 7.8 | 96 | 35.8 | 86 | 32.1 | 46 | 17.2 | 19 | 7.1 |
2011-2015 | 247 | 19 | 7.7 | 94 | 38.1 | 78 | 31.6 | 38 | 15.4 | 18 | 7.3 |
2010-2014 | 237 | 15 | 6.3 | 85 | 35.9 | 79 | 33.3 | 38 | 16.0 | 20 | 8.4 |
2009-2013 | 236 | 12 | 5.1 | 90 | 38.1 | 78 | 33.1 | 36 | 15.3 | 20 | 8.5 |
2008-2012 | 228 | 9 | 3.9 | 82 | 36.0 | 71 | 31.1 | 41 | 18.0 | 25 | 11.0 |
2007-2011 | 212 | 5 | 2.4 | 73 | 34.4 | 68 | 32.1 | 37 | 17.5 | 29 | 13.7 |
2006-2010 | 224 | 4 | 1.8 | 85 | 37.9 | 66 | 29.5 | 38 | 17.0 | 31 | 13.8 |
2005-2009 | 229 | 4 | 1.7 | 87 | 38.0 | 66 | 28.8 | 38 | 16.6 | 34 | 14.8 |
2004-2008 | 224 | 5 | 2.2 | 85 | 37.9 | 67 | 29.9 | 34 | 15.2 | 33 | 14.7 |
2003-2007 | 227 | 6 | 2.6 | 89 | 39.2 | 69 | 30.4 | 32 | 14.1 | 31 | 13.7 |
2002-2006 | 241 | 4 | 1.7 | 94 | 39.0 | 80 | 33.2 | 33 | 13.7 | 30 | 12.4 |
2001-2005 | 234 | 7 | 3.0 | 81 | 34.6 | 84 | 35.9 | 29 | 12.4 | 33 | 14.1 |
2000-2004 | 239 | 7 | 2.9 | 84 | 35.1 | 93 | 38.9 | 27 | 11.3 | 28 | 11.7 |
1999-2003 | 259 | 10 | 3.9 | 87 | 33.6 | 96 | 37.1 | 35 | 13.5 | 31 | 12.0 |
1998-2002 | 267 | 10 | 3.7 | 81 | 30.3 | 114 | 42.7 | 33 | 12.4 | 29 | 10.9 |
1997-2001 | 259 | 12 | 4.6 | 73 | 28.2 | 110 | 42.5 | 34 | 13.1 | 30 | 11.6 |
1996-2000 | 256 | 11 | 4.3 | 67 | 26.2 | 103 | 40.2 | 38 | 14.8 | 37 | 14.5 |
1995-1999 | 269 | 11 | 4.1 | 66 | 24.5 | 102 | 37.9 | 44 | 16.4 | 46 | 17.1 |
1994-1998 | 246 | 8 | 3.3 | 67 | 27.2 | 89 | 36.2 | 36 | 14.6 | 46 | 18.7 |
1993-1997 | 227 | 9 | 4.0 | 65 | 28.6 | 68 | 30.0 | 34 | 15.0 | 51 | 22.5 |
1992-1996 | 228 | 10 | 4.4 | 65 | 28.5 | 64 | 28.1 | 31 | 13.6 | 58 | 25.4 |
1991-1995 | 227 | 8 | 3.5 | 69 | 30.4 | 64 | 28.2 | 26 | 11.5 | 60 | 26.4 |
1990-1994 | 204 | 9 | 4.4 | 56 | 27.5 | 59 | 28.9 | 18 | 8.8 | 62 | 30.4 |
1989-1993 | 203 | 9 | 4.4 | 42 | 20.7 | 64 | 31.5 | 22 | 10.8 | 66 | 32.5 |
1988-1992 | 209 | 7 | 3.3 | 49 | 23.4 | 61 | 29.2 | 23 | 11.0 | 69 | 33.0 |
1987-1991 | 203 | 5 | 2.5 | 55 | 27.1 | 55 | 27.1 | 21 | 10.3 | 67 | 33.0 |
1986-1990 | 196 | 6 | 3.1 | 56 | 28.6 | 50 | 25.5 | 19 | 9.7 | 65 | 33.2 |
1985-1989 | 202 | 6 | 3.0 | 64 | 31.7 | 55 | 27.2 | 18 | 8.9 | 59 | 29.2 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |